109 filings
Page 3 of 6
8-K
m9rmzz97ywhavxl80rv
2 Oct 20
Other Events
5:19pm
8-K
l6ycsunab
28 Sep 20
Submission of Matters to a Vote of Security Holders
4:56pm
8-K
hafnd 09379m
11 Aug 20
Results of Operations and Financial Condition
7:01am
8-K
6gq k0qtclb7h6f1
10 Jun 20
Axovant Announces Year-End Financial Results and Expected Key Clinical Milestones in Q4 2020
6:02am
8-K
jna81g2bsu
29 Apr 20
Entry into a Material Definitive Agreement
5:00pm
8-K
1qhipp0d8
24 Apr 20
Other Events
7:31am
8-K
w9oi47a0k4
20 Apr 20
Termination of a Material Definitive Agreement
5:21pm
8-K
zaexlwys1q0xfibdkrv5
26 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
hiju2afhbv ey2
21 Feb 20
Other Events
5:16pm
8-K
v33 fae8c0
19 Feb 20
Departure of Directors or Certain Officers
6:01am
8-K
y7cq0
10 Feb 20
Results of Operations and Financial Condition
6:05am
8-K
evbfnrgo3qh64qkizj2p
13 Jan 20
Regulation FD Disclosure
6:43am
8-K
rqxc78g43httwjt0v fj
3 Dec 19
Axovant Announces Amendment to Credit Facility with Hercules Capital
7:19am
8-K
jiil9861oasttbqkfo
8 Nov 19
Departure of Directors or Certain Officers
4:53pm
8-K
vlrdxyynzlan 0fhl
8 Nov 19
Results of Operations and Financial Condition
8:03am
8-K
68t03rtht rrmlxq
23 Oct 19
Axovant Presents First Evidence of Clinical Stabilization in Tay-Sachs Disease at the European Society of Gene and Cell Therapy 27th Annual Congress
7:03am
8-K
o4wvh89li4d0s53dy0sw
24 Sep 19
Departure of Directors or Certain Officers
5:12pm
8-K
y7u jq3saqe
6 Sep 19
Other Events
7:30am
8-K
31lr8m7dav55b19k26
16 Aug 19
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
r9h39
9 Aug 19
Results of Operations and Financial Condition
7:03am